Irish-based company secures first U.S. regulatory clearance for its Millipede 088 Access Catheter from the Food and Drug Administration (FDA) The company is also developing catheter-based technology ...

GALWAY, Ireland--(BUSINESS WIRE)--Perfuze, a private medical device company dedicated to developing pioneering technology to treat acute ischemic stroke, proudly announces FDA clearance for the ...

Galway-based Perfuze, a private medical device company dedicated to developing pioneering technology to treat acute ischemic stroke, announced US FDA clearance for the Millipede 070 Aspiration ...

GALWAY, Ireland, March 17, 2026--(BUSINESS WIRE)--Perfuze, a medical device company dedicated to advancing stroke treatment through next-generation catheter technology, today announced it has received ...

Perfuze, a private medical device company dedicated to developing pioneering technology to treat acute ischemic stroke, announced commencement of enrollment in its pivotal MARRS (Millipede AspiRation ...

Perfuze announces that the first five acute ischemic stroke patients have been treated with its clot aspiration catheter, Millipede 088. Perfuze received CE Mark approval for its flagship product in ...

Perfuze is developing catheter-based technology to remove blood clots from the brain and treat acute ischemic stroke. Galway-based medtech start-up Perfuze has raised €22.5m in a Series A funding ...

GALWAY, Ireland, March 13, 2025--(BUSINESS WIRE)--Perfuze, a leading medical device company dedicated to advancing stroke treatment, today announced that it has received FDA 510(k) clearance for its ...

The US Food and Drug Administration (FDA) has cleared Perfuze’s Zipline single-use access catheter for acute ischemic stroke (AIS) procedures. The Irish company’s medical device is used in delivering ...

Galway-based medtech company Perfuze has raised €22.5 million in funding for the development of a new stroke treatment. Founded by Wayne Allen and Liam Mullins in 2018, two years after they sold their ...